Diarrhea News and Research

Latest Diarrhea News and Research

Study highlights benefits and risks of doxy-PEP for STI prevention

Taking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted infections (STIs) in places where the strategy is being tried.

4 Oct 2024

Breast milk antibodies linked to protection against rotavirus in infants

A study led by researchers at the University of Rochester Medical Center found that breast milk provides protection against rotavirus, a common gastrointestinal disease that causes diarrhea, vomiting and fever in infants.

1 Oct 2024

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

Study reveals that over 93% of primary care patients expect antibiotics for common symptoms, especially in public clinics, with lack of education and health literacy contributing to these unrealistic expectations. Knowledge of antibiotic risks is a key factor influencing patient demand.

29 Sep 2024

Global leaders unite to tackle drug-resistant bacteria

World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the problem of drug-resistant bacteria, a global crisis that is all the more acute in the poorest countries.

27 Sep 2024

Climate change to drive increased hospitalizations from diarrheal diseases in Dhaka

By 2100, hospitalizations from diarrheal diseases are predicted to increase in the city of Dhaka in Bangladesh as a result of climate change, even if global warming stays under 2 degrees Celsius.

26 Sep 2024

Genetic factors that make the bacteria behind cholera so dangerous uncovered

Study reveals key genetic factors in Vibrio cholerae O1 that drive cholera transmission and severity, highlighting targets for novel therapeutic strategies.

26 Sep 2024

Targeted drug therapy shows promise for ulcerative colitis remission

An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.

26 Sep 2024

IBD increases type 1 diabetes risk, revealing a bidirectional link between the two conditions

Researchers discovered that IBD significantly increases the risk of developing T1D, and this association works both ways, independent of genetics and familial factors. The strongest link was seen in ulcerative colitis patients.

19 Sep 2024

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

17 Sep 2024

Study finds immunotherapy effective for prostate cancer with certain DNA errors

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors.

16 Sep 2024

Zongertinib shows promising efficacy in HER2 mutation-positive NSCLC

The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients with HER2 mutation-positive non-small cell lung cancer, meeting the primary endpoint of the Beamion LUNG-1 Phase Ib Cohort 1 study, according to research presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer.

11 Sep 2024

Severe illness odds higher in COVID-19 vs other illnesses

Study found that COVID-19 cases were more likely to experience severe illness and persistent symptoms compared to non-COVID-19 respiratory illnesses, with age, preexisting conditions, and chronic respiratory disease increasing the risk of post-acute COVID-19 syndrome (PACS).

10 Sep 2024

Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Study analyzes self-reported long COVID symptoms through a healthcare app, revealing that symptom severity significantly varies by demographic factors such as age, gender, race, education, and socioeconomic status.

2 Sep 2024

Fermented lingonberry juice shown to reduce inflammation and support gut health in IBD

Fermented lingonberry juice may help manage inflammatory bowel disease (IBD) by modulating both the oral and gut microbiomes, reducing inflammation, and promoting beneficial bacteria.

2 Sep 2024

The Arctic Sea revealed as a potential treasure trove for new medicines

Researchers discovered new antivirulence and antibacterial compounds from Arctic marine actinobacteria, offering potential solutions to combat antibiotic-resistant E. coli infections.

30 Aug 2024

CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns

The CDC reports 21 new cases of Oropouche virus among U.S. travelers from Brazil and Cuba, highlighting potential health risks and the need for vigilant monitoring and preventive measures.

29 Aug 2024

Gut microbiota plays a critical role in rotavirus vaccine efficacy

Certain types of gut bacteria can hinder the efficacy of the rotavirus vaccine, according to researchers at the Institute for Biomedical Sciences at Georgia State University.

27 Aug 2024

Mediterranean diet lowers COVID-19 risk, but its effect on symptoms and severity remains uncertain

Higher adherence to the Mediterranean diet is associated with a reduced risk of COVID-19, but its effects on symptom severity are less certain due to mixed results and study limitations.

27 Aug 2024

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

Research on a modified TNT regimen for high-risk rectal cancer reveals similar complete response rates and lower toxicity compared to traditional approaches.

26 Aug 2024

Expanded use of common antibiotic cuts child mortality by 14% in Sub-Saharan Africa

When UC San Francisco research showed that routinely treating children in Sub-Saharan Africa with a common antibiotic could reduce deaths in children under five, the World Health Organization (WHO) moved quickly to recommend the treatment – but only for infants between 1 and 11 months old.

22 Aug 2024

Diarrhea News and Research

Latest Diarrhea News and Research

Study highlights benefits and risks of doxy-PEP for STI prevention

Breast milk antibodies linked to protection against rotavirus in infants

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

Global leaders unite to tackle drug-resistant bacteria

Climate change to drive increased hospitalizations from diarrheal diseases in Dhaka

Genetic factors that make the bacteria behind cholera so dangerous uncovered

Targeted drug therapy shows promise for ulcerative colitis remission

IBD increases type 1 diabetes risk, revealing a bidirectional link between the two conditions

Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Study finds immunotherapy effective for prostate cancer with certain DNA errors

Zongertinib shows promising efficacy in HER2 mutation-positive NSCLC

Severe illness odds higher in COVID-19 vs other illnesses

Long COVID symptom severity varies widely by age, gender, and socioeconomic status

Fermented lingonberry juice shown to reduce inflammation and support gut health in IBD

The Arctic Sea revealed as a potential treasure trove for new medicines

CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns

Gut microbiota plays a critical role in rotavirus vaccine efficacy

Mediterranean diet lowers COVID-19 risk, but its effect on symptoms and severity remains uncertain

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

Expanded use of common antibiotic cuts child mortality by 14% in Sub-Saharan Africa

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in